Accelerated Stability Studies of Heparin
- 1 January 1996
- journal article
- Published by American Geophysical Union (AGU) in Journal of Pharmaceutical Sciences
- Vol. 85 (1) , 45-51
- https://doi.org/10.1021/js9502736
Abstract
The objective of this study was to extend our understanding of the stability of heparin. Sodium heparin, derived from porcine intestinal mucosa, was first incubated in 0.1 N hydrochloric acid and 0.1 N sodium hydroxide at 30 and 60 degrees C and sampled at times ranging from 0 to 1000 h. The absorbance spectra of the products formed under basic conditions showed an ultraviolet maxima at 232 nm associated with chemically catalyzed beta-elimination at the uronic acid residues. The products formed under acidic conditions showed a decreased staining intensity consistent with desulfation and a decrease in molecular weight corresponding to hydrolysis of glycosidic linkages when analyzed by gradient polyacrylamide gel electrophoresis. Heparin samples were next prepared in 10 mM sodium phosphate buffer at pH 7.0 in sealed ampules that had been flushed with nitrogen and incubated at 100 degrees C. Samples taken at times ranging from 0 to 4000 h were then analyzed. Heparin was relatively stable over the first 500 h, after which it rapidly degraded. Heparin, assayed using both anti-factor Xa and anti-factor IIa amidolytic methods retained 80-90% of its activity over the first 500 h, but these activities dropped precipitously, to approximately 6% and approximately 0.5% of the initial activity at 1000 h and 2000 h, respectively. This rapid decomposition began only after the buffering capacity of the solution was overwhelmed by acidic degradants, which caused the pH to decrease. Decomposition processes observed under these conditions included the endolytic hydrolysis of glycosidic linkages and loss of sulfation, particularly N-sulfate groups, and were similar to the degradation processes observed in 0.1 N hydrochloric acid. This study provides initial observations on heparin degradation pathways. More complete, quantitative studies and studies leading to the isolation and characterization of specific degradants are still required.Keywords
This publication has 19 references indexed in Scilit:
- Interaction of heparin with synthetic antithrombin III peptide analoguesBiochemical Journal, 1994
- Pharmacodynamics, Clinical Indications, and Adverse Effects of HeparinThe Journal of Clinical Pharmacology, 1992
- Heparinase II from Flavobacterium heparinumEuropean Journal of Biochemistry, 1991
- Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processesPhysiological Reviews, 1991
- Oligosaccharide mapping of low-molecular-weight heparins: structure and activity differencesJournal of Medicinal Chemistry, 1990
- Depolymerization of heparin with diazomethane. Structure of N,O-methylated, even-numbered oligosaccharides produced by β-eliminative cleavage of the 2-amino-2-deoxyglycosylic linkageCarbohydrate Research, 1984
- The acid lability of the glycosidic bonds of l-iduronic acid residues in glycosaminoglycansBiochemical Journal, 1980
- Structure of the antithrombin-binding site in heparin.Proceedings of the National Academy of Sciences, 1979
- Correlation between structure and function of heparinProceedings of the National Academy of Sciences, 1979
- Solvolytic desulfation of glycosaminoglycuronan sulfates with dimethyl sulfoxide containing water or methanolCarbohydrate Research, 1977